Folinic Acid and Neurological Function

Introduction to Folinic Acid

Folinic acid (5-formyltetrahydrofolate), also known as Leucovorin, is a bioactive form of folate (vitamin B9) essential for neurological development and function. It is involved in DNA synthesis, methylation, and neurotransmitter production. Disruptions in folate metabolism can impair folate transport into the brain, leading to cerebral folate deficiency (CFD), especially in neurodevelopmental conditions such as autism spectrum disorder (ASD) and PANS/PANDAS.

Folate Receptor Alpha Autoantibodies (FRAAs)

Types and Mechanisms

Folate receptor alpha (FRα) is a protein that facilitates folate uptake into the central nervous system (CNS). The immune system can produce folate receptor alpha autoantibodies (FRAAs) that disrupt this process, even when systemic folate levels are normal. There are two main types of FRAAs:

• Blocking FRAAs: Directly prevent folate from binding to its receptor, obstructing transport into the CNS.

• Binding FRAAs: Indirectly alter receptor function, often through inflammatory mechanisms.

These autoantibodies are particularly relevant in children with speech and language delays or non-speaking ASD.

Soluble Folate Receptor Alpha (sFRα) and Diagnostic Challenges

The soluble form of folate receptor alpha (sFRα) can circulate in the bloodstream, binding to folate and forming complexes. This can interfere with laboratory assays for FRAAs by:

• Masking autoantibodies, reducing their detectability.

• Competing with membrane-bound FRα, affecting assay accuracy.

This may lead to false negatives, causing missed diagnoses and delayed treatment.

Prevalence and Clinical Impact of FRAAs

Prevalence in Neurodevelopmental Disorders

Research shows that approximately 70% of children with ASD have FRAAs, compared to 5–10% of the general population. In PANS/PANDAS, 63.8% of children tested positive for FRAAs, with most exhibiting binding antibodies. FRAAs are associated with impaired folate transport and neurological symptoms.

Therapeutic Role of Folinic Acid

Folinic acid can bypass the FRα pathway by using the reduced folate carrier (RFC) to enter the CNS. Clinical protocols recommend doses up to 2 mg/kg/day (maximum 50 mg/day) to restore CNS folate levels. Supplementation has been shown to improve expressive language, social engagement, and cognitive function in affected children.

Dietary and Environmental Factors Affecting FRAAs

Dairy Products and Molecular Mimicry

Consumption of animal-derived milk (cow, goat, sheep, camel) is linked to the production of FRAAs in susceptible children. This is due to molecular mimicry, where milk proteins resemble human folate receptors, triggering an autoimmune response. A strict dairy-free diet is recommended for children with FRAAs to reduce antibody activity and support folate transport.

Other Causes of Raised FRAAs

• Lingering Infections & Autoimmunity: Chronic infections (e.g., EBV, CMV, HHV-6, Strep, Mycoplasma, Lyme) can trigger molecular mimicry and FRAA production.

• Gut Health & Clostridia Overgrowth: Leaky gut and microbial toxins (LPS, 4-cresol, HPHPA) can disrupt immune and brain function, interfering with folate pathways.

• Environmental Toxins: Heavy metals (mercury, lead), glyphosate, and aluminium can disrupt folate metabolism and immune function. Aluminium may block folate transport and enzyme activity.

Key Studies on Folinic Acid and Autism

Summary of Research Findings

• Randomized Controlled Trials: High-dose folinic acid (2 mg/kg/day, up to 50 mg/day) improved verbal communication in children with ASD, especially those with FRAAs.

• Clinical Benefits: Improvements noted in daily living skills, irritability, stereotyped behavior, and hyperactivity.

• Safety and Efficacy: Folinic acid was well-tolerated and led to behavioral improvements in open-label studies.

• Systematic Reviews: Folinic acid can bypass FRAA-induced blockages, restoring brain folate and supporting neuronal function.

• Combination Therapy: Folinic acid with methylcobalamin (vitamin B12) improved antioxidant defenses and reduced oxidative stress in children with ASD.

Further research is needed to refine treatment protocols, but folinic acid is a promising intervention for children with ASD and related neuroimmune conditions.

References

• Biological, dietetic and pharmacological properties of vitamin B9

• Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis

• Correction: Rossignol, D.A.; Frye, R.E. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. J. Pers. Med. 2021, 11, 1141

• Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism

• Efficacy of oral folinic acid supplementation in children with autism spectrum disorder: a randomized double-blind, placebo-controlled trial

• Cerebral Folate Deficiency Syndrome: Early Diagnosis, Intervention and Treatment Strategies

• Folate Receptor Alpha Autoantibodies in Autism Spectrum Disorders: Diagnosis, Treatment and Prevention

• Folic Acid and Autism: A Systematic Review of the Current State of Knowledge

• Folinic acid as a treatment for autism in children: A within-subjects open-label study on safety and efficacy

• Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial

• Folinic acid improves the score of Autism in the EFFET placebo-controlled randomized trial

• Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial

• Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder

• A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome

• Cerebral folate deficiency: A report of two affected siblings

• Progressive Encephalopathy in a Child With Cerebral Folate Deficiency Syndrome

• Folate Receptor Alpha Autoantibodies in the Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) Population